Estado
212%
financiada
Compartir
Datos de financiación (05/08/2025)
Contribuido
GBP
63.758.466,00
Objetivo máximo
GBP
30.000.000,00
Inversión mínima
GBP
4.726,00
Detalles
País
Reino Unido
Tipología
Equity
Fecha final
05/08/2025
(325 días)
contribuidores
160
Descripción
“Digostics is transforming diabetes care with GTT@home — the world’s first at-home oral glucose tolerance test (OGTT). Our CE-marked digital platform delivers home-based diabetes screening, supporting earlier detection and relieving healthcare system pressures. Adopted by NHS Trusts and approved in multiple markets, Digostics is redefining diabetes detection.”